Maraveyas A, Johnson M, Xiao YP, Noble S. Malignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins. Cancer and Metastasis Reviews 2010 Dec;29(4):777-84.
http://www.springerlink.com/content/pg8km058275pm4l1/ Noble SIR, Pasi J. Pathophysiology of cancer associated thrombosis. British Journal of Cancer. 2010;102;S2-S9
http://journals.lww.com/md-journal/Citation/1999/09000/Rates_of_Initial_and_Recurrent_Thromboembolic.1.aspx Griffiths GO, Burns S, Noble SI, Macbeth FR, Maughan TS. FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer. BMC Cancer 2009 BMC Cancer 2009, 9:355.
Noble SIR, Jenkins DA. The management of venous thromboembolism in patients with cancer. British Journal of Hospital Medicine. 2009 8;70(7):380-385.
Maraveyas A and Johnson MJ. Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? British Journal of Cancer 2009; 100: 1837-1841; doi: 10.1038/sj.bjc.6605091
Noble S. A step in the right direction but one size might not fit all. Lancet Oncology 2009 Oct;10(10):930-1
Johnson MJ. Venous thromboembolism: not as easy as it looks. (Editorial) British Journal of Hospital Medicine. 2009; 70 (7): 176 – 177
Anthony Maraveyas. Pancreatic cancer: A model cancer for the study of the therapeutic effects of anticoagulants World J Gastrointest Oncol 2009 October 15; 1(1): 38-40
Noble SI, Shelley M, Coles B, Williams S, Wilcock A, Johnson M. Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis by the thrombosis task group, on behalf of the Association for Palliative Medicine Science Committee. Lancet Oncology 2008, 9(6):577-84
Sgouros J, Maraveyas A. Premature (3-month) mortality in advanced pancreatic cancer could be related to fatal vascular thromboembolic events. A hypothesis based on a systematic review of phase III chemotherapy studies in advanced pancreatic cancer. Acta Oncol. 2008;47(3):337-46
Noble SIR, Nelson A, Finlay IG. Factors influencing hospice thromboprophylaxis policy: a qualitative study. Palliative Medicine, 4. 2008;22(7):808-13
Noble S. Venous thromboembolism in cancer patients. MIMS Oncology and Palliative Care. 2008; 2 (2):30-33
Noble SIR. The challenges of managing cancer related venous thromboembolism in the palliative care setting. Postgraduate Medical Journal, 2007; 83: 671-674 Noble SIR, Hood K, Finlay IG. The use of long-term low molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients. Palliative Medicine, 2007; 21(6):473-6
Noble S. The management of venous thromboembolism in the palliative care setting. International Journal of Palliative Nursing. 2007, (13) 12, 574- 579
Noble SIR, Finlay IG. Have Palliative Care Teams’ attitudes to venous thromboembolism changed? A survey of thromboprophylaxis practice across British Specialist Palliative Care Units in the years 2000 and 2005 Journal of Pain and Symptom Management. 2006 Jul;32(1):38-43.
Noble S, Nelson A, Turner C, Finlay I. Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study. BMJ 2006 Mar 11;332(7541):577-80.
Noble S, Nelson A. Palliative care can include prophylaxis. NT. Apr 2006. 102 (14) 16
Noble SIR, Finlay IG. Is long-term low molecular weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study. Palliative Medicine. 2005; 19: 197-201
Noble SIR. Home-treatment of deep vein thrombosis in patients with cancer: quality of life impact of therapies. Haematologica. 2005 Nov;90 Suppl:ELT06.
Noble SIR. Anticoagulation in advanced malignancy. Thrombus 2005; 8(4): 1-3
Johnson MJ. Anticoagulation and patients with advanced cancer. CME Bulletin Palliative Care. 2001;
Johnson MJ, Sproule MW, Paul J. The prevalence and associated variables of deep venous thrombosis in patients with advenced cancer. Clinical Oncology. 1999; 11: 105–110.
Johnson MJ, Walker ID, Sproule MW, Conkie J. Abnormal coagulation and deep venous thrombosis in patients with advanced cancer. Clinical and Laboratory Haematology. 1999: 21; 51–54.
Johnson MJ. Venous thromboembolism and advanced cancer. Palliative Care Today. 1999; 8: 6–7.
Johnson MJ. Problems of anticoagulation within a palliative care setting: an audit of hospice patients taking warfarin. Palliative Medicine. 1997; 11: 306–312.(correction Palliative Medicine. 1998; 12: 463.)
Johnson MJ, Sherry K. How do palliative physicians manage venous thromboembolism? Palliative Medicine. 1997; 11: 462–468.
